Connection
Edward Hoffenberg to Cost-Benefit Analysis
This is a "connection" page, showing publications Edward Hoffenberg has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.073 |
|
|
|
-
Condino AA, Fidanza S, Hoffenberg EJ. A home infliximab infusion program. J Pediatr Gastroenterol Nutr. 2005 Jan; 40(1):67-9.
Score: 0.049
-
Park KT, Crandall WV, Fridge J, Leibowitz IH, Tsou M, Dykes DM, Hoffenberg EJ, Kappelman MD, Colletti RB. Implementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2014 May; 20(5):946-51.
Score: 0.023